Immune monitoring for mold infections
Part of Infections clinical trials.
This study tracks how your immune system responds to serious mold infections, like aspergillosis or mucormycosis. It may help doctors understand why some infections are hard to treat and could lead to better care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a proven or probable mold infection (like Aspergillus, Mucorales, Fusarium, or Scedosporium).
- You were diagnosed within the last 14 days, or your infection is not responding to current treatment.
- Your lymphocyte count (a type of white blood cell) is above 700 per cubic millimeter.
- You have not had a bacterial infection in the last 14 days.
- You have not been treated with anti-PD1 immunotherapy before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study enrolls people who have test results showing an invasive fungal infection (a fungus causing illness inside the body). The goal is to build a global registry to better understand these infections and improve future care.
This study looks for specific lab “biomarkers” in people with mucormycosis, a serious fungal infection. It compares results with people who have higher infection risk but no active infection, to help doctors diagnose and track this illness more accurately.
This study tests a new antifungal drug (EL219) compared to two standard treatments (liposomal amphotericin B or voriconazole) for people with weakened immune systems who have a suspected or confirmed mold infection. The goal is to see if the new drug works as well or better at treating the infection.
This study looks at how immune system problems relate to fungal infections, using medical records and lab tests on blood and tissue. It may help researchers understand the cause of these infections—especially for people with inherited immune conditions—and improve future care.
This study uses noninvasive breathing/relates imaging (MRI or CT) to help diagnose mold infections in the lungs in children and young adults. It may help doctors find these infections sooner, especially in people with weakened immune systems.
This study is testing a new imaging agent to see if it can help detect invasive mold infections in the body. It will involve healthy volunteers and people with certain types of fungal infections.
Hear when a new Invasive Fungal Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.